![]() |
| Brazil's Biotech Firms: From Imitators To Innovators In Hea |
|
RSS FEED
|
Brazil is in the midst of a transition from imitator to innovator in health-related products, according to the most comprehensive analysis to date of barriers and opportunities facing that country's health biotech industry.In the third study of its kind, the McLaughlin-Rotman Centre for Global Health (MRC), says South America's largest and most populous country has the scientific and market capacity to emerge as a major global player.
Read more... |
||||||||||||
|
|
|||||||||||||
| Brazil's Biotech Firms: From Imitators To Innovators In Hea |
|
||
|
Site Map
|
Sitemap |
